• OPEN AN ACCOUNT
Indian Indices
Nifty
25,461.00 55.70
(0.22%)
Sensex
83,432.89 193.42
( 0.23%)
Bank Nifty
57,031.90 239.95
( 0.42%)
Nifty IT
39,166.55 312.25
( 0.80%)
Global Indices
Nasdaq
44,849.54 344.11
(0.77%)
Dow Jones
6,300.35 51.93
(0.83%)
Hang Seng
39,792.23 6.33
(0.02%)
Nikkei 225
8,822.91 -0.29
(0.00%)
Forex
USD-INR
85.44 -0.20
(-0.23%)
EUR-INR
100.61 -0.32
(-0.32%)
GBP-INR
116.59 -0.52
(-0.45%)
JPY-INR
0.59 0.00
(-0.64%)

EQUITY - MARKET SCREENER

Deccan Health Care Ltd
Industry :  Food - Processing - Indian
BSE Code
ISIN Demat
Book Value()
542248
INE452W01019
45.4869496
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
41.24
49.26
EPS(TTM)
Face Value()
Div & Yield %
0.51
10
0
 

ideaum technologies ltd
Polyplex Corp slumps after weak Q4 performance
May 29,2025

Net sales rose by 3.6% to Rs 1,739.56 crore in Q4 March 2025 over Q4 March 2024.

The company posted a pre-tax loss of Rs 5.61 crore in the fourth quarter as against a pre-tax profit of Rs 21.13 crore recorded in the same period last year.

Total operating expenditure rose 5.9% to Rs 1,675.66 crore in Q4 FY25 over Q4 FY24. During the quarter, cost of materials consumed stood at Rs 1,057.12 crore (down 12.5% YoY) while employee benefits expense was at Rs 160.16 crore (down 7.8% YoY). Other expenses increased by 52.5% YoY to Rs 315.41 crore in Q4 FY25.

PBIDT came in at Rs 81.63 crore, down 28% YoY. PBIDT margin was 4.69% in Q4 FY25 as against 6.75% in Q4 FY24.

For the full year FY25, net sales 9.2% YoY to Rs 6,885.18 crore, while net profit increased by 5.5x YoY to Rs 209.21 crore.

Polyplex Corporation’s product portfolio includes PET films (thin & thick), BOPP, cast polypropylene and blown polypropylene. These products are used in flexible packaging besides several industrial applications such as tapes, labels, thermal lamination, imaging and graphics, photo-voltaic and optical applications.